Cargando…

Young-onset atrial fibrillation: Sex differences in clinical profile, progression rate and cardiovascular outcome()

BACKGROUND: Women are underrepresented in major atrial fibrillation (AF) trials. In addition, data regarding clinical profile and outcome in young AF patients is limited. Therefore we aimed to investigate the clinical profile, AF progression rate and cardiovascular outcome between sexes in patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marcos, Ernaldo G., De With, Ruben R., Mulder, Bart A., Van Gelder, Isabelle C., Rienstra, Michiel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6923497/ https://www.ncbi.nlm.nih.gov/pubmed/31890859 http://dx.doi.org/10.1016/j.ijcha.2019.100429

Ejemplares similares

Update on management of atrial fibrillation in heart failure: a focus on ablation
por: Mulder, Bart A, et al.
Publicado: (2022)

Incidence and outcome of atrial fibrillation: diversity throughout Europe
por: Rienstra, Michiel, et al.
Publicado: (2021)

Atrial fibrillation and heart failure temporality: does it matter?
por: Van Deutekom, Colinda, et al.
Publicado: (2022)

Time of onset of atrial fibrillation and atrial fibrillation progression data from the RACE V study
por: van de Lande, Martijn E, et al.
Publicado: (2023)

Sex-related differences in risk factors, outcome, and quality of life in patients with permanent atrial fibrillation: results from the RACE II study
por: Kloosterman, Mariëlle, et al.
Publicado: (2019)

Cardiovascular and renal multimorbidity increase risk of atrial fibrillation in the PREVEND cohort
por: Van Deutekom, Colinda, et al.
Publicado: (2023)

Assessment of sex-related differences and outcome in patients who underwent cryoballoon pulmonary vein isolation for atrial fibrillation: an observational cohort study
por: Ekrami, Neda Khalilian, et al.
Publicado: (2022)

Initial experience with pulsed field ablation for atrial fibrillation
por: Magni, Federico T., et al.
Publicado: (2022)

Telomere length and incident atrial fibrillation – data of the PREVEND cohort
por: Siland, Joylene E., et al.
Publicado: (2017)

Rate control drugs differ in the prevention of progression of atrial fibrillation
por: Koldenhof, Tim, et al.
Publicado: (2021)

Prevalence and determinants of atrial fibrillation progression in paroxysmal atrial fibrillation
por: Nguyen, Bao-Oanh, et al.
Publicado: (2023)

First-line treatment of persistent and long-standing persistent atrial fibrillation with single-stage hybrid ablation: a 2-year follow-up study
por: Magni, Federico T, et al.
Publicado: (2021)

Identifying patients with atrial fibrillation recurrences after two pulmonary vein isolation procedures
por: Mulder, Bart A, et al.
Publicado: (2021)

Cluster Individuals Based on Phenotype and Determine the Risk for Atrial Fibrillation in the PREVEND and Framingham Heart Study Populations
por: Rienstra, Michiel, et al.
Publicado: (2016)

Relation of overweight and symptomatic atrial fibrillation: A case report
por: de Maat, Gijs E., et al.
Publicado: (2015)

Cardioversion of atrial fibrillation and atrial flutter revisited: current evidence and practical guidance for a common procedure
por: Brandes, Axel, et al.
Publicado: (2020)

Pulsed field (endocardial) ablation as part of convergent hybrid ablation for the treatment of long-standing persistent atrial fibrillation
por: Magni, Federico T., et al.
Publicado: (2022)

Hybrid atrial fibrillation ablation in patients with persistent atrial fibrillation or failed catheter ablation
por: Al-Jazairi, M. I. H., et al.
Publicado: (2019)

Heart rate increase and inappropriate sinus tachycardia after cryoballoon pulmonary vein isolation for atrial fibrillation
por: van Deutekom, C., et al.
Publicado: (2021)

Atrial fibrillation detected at screening is not a benign condition: outcomes in screen-detected versus clinically detected atrial fibrillation. Results from the Prevention of Renal and Vascular End-stage Disease (PREVEND) study
por: Zwartkruis, Victor W, et al.
Publicado: (2021)

Lifestyle components: Self-reported physical activity, nutritional status, sleep quality and incident atrial fibrillation
por: Siland, Joylene E., et al.
Publicado: (2020)

Genetically-determined body mass index and the risk of atrial fibrillation progression in men and women
por: Siland, J. E., et al.
Publicado: (2021)

Clustering of cardiovascular and renal comorbidities and risk of incident atrial fibrillation in the community-based PREVEND cohort
por: Van Deutekom, C, et al.
Publicado: (2023)

Prevalence and Incidence of Atrial Fibrillation in Heart Failure with Mildly Reduced or Preserved Ejection Fraction: (Additive) Value of Implantable Loop Recorders
por: Gorter, Thomas M., et al.
Publicado: (2023)

Pulmonary vein anatomy addressed by computed tomography and relation to success of second‐generation cryoballoon ablation in paroxysmal atrial fibrillation
por: Mulder, Bart A., et al.
Publicado: (2019)

Cardioversion strategy impacts quality of rate control during recurrences of atrial fibrillation
por: Van Der Velden, R, et al.
Publicado: (2023)

Rate control with calcium channel blockers versus betablockers in patients with paroxysmal and persistent atrial fibrillation - data from the AFFIRM trial
por: Koldenhof, T, et al.
Publicado: (2023)

Atrial Fibrillation Genetics Update: Toward Clinical Implementation
por: Kalstø, Silje Madeleine, et al.
Publicado: (2019)

Validating risk models versus age alone for atrial fibrillation in a young Dutch population cohort: should atrial fibrillation risk prediction be expanded to younger community members?
por: Himmelreich, Jelle C L, et al.
Publicado: (2022)

Effectiveness and safety of dabigatran versus acenocoumarol in ‘real-world’ patients with atrial fibrillation
por: Korenstra, Jennie, et al.
Publicado: (2016)

Atrial fibrillation and left atrial size and function: a Mendelian randomization study
por: van de Vegte, Yordi J., et al.
Publicado: (2021)

Clinical utility of the 4S-AF scheme in predicting progression of atrial fibrillation: data from the RACE V study
por: Artola Arita, Vicente, et al.
Publicado: (2023)

Heart failure with preserved ejection fraction, atrial fibrillation, and the role of senile amyloidosis
por: van den Berg, Maarten P, et al.
Publicado: (2019)

Temporal patterns and short-term progression of paroxysmal atrial fibrillation: data from RACE V
por: De With, Ruben R, et al.
Publicado: (2020)

Left atrial sphericity in relation to atrial strain and strain rate in atrial fibrillation patients
por: Hopman, Luuk H.G.A., et al.
Publicado: (2023)

New-onset perioperative atrial fibrillation in cardiac surgery patients: transient trouble or persistent problem?—Authors’ reply
por: Kawczynski, Michal J, et al.
Publicado: (2021)

Integrated care in patients with atrial fibrillation- a predictive heterogeneous treatment effect analysis of the ALL-IN trial
por: Trinks-Roerdink, Emmy M., et al.
Publicado: (2023)

New‐onset atrial fibrillation in a young patient detected by smartwatch
por: Samal, Subhankar, et al.
Publicado: (2020)

Ethnic differences in atrial fibrillation among patients with heart failure in Asia
por: Tan, Eugene S.J., et al.
Publicado: (2020)

Brady- and tachyarrhythmias detected by continuous rhythm monitoring in paroxysmal atrial fibrillation
por: Frausing, Maria Hee Jung Park, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4h17dkh8248ble2lgaqv9p17jd